REGULUS THERAPEUTICS INC.

(RGLS)
  Report
Delayed Nasdaq  -  04:00 2022-06-30 pm EDT
2.070 USD   -1.43%
06/28Wall Street Set to Open Higher
MT
06/28Top Premarket Decliners
MT
06/27REGULUS THERAPEUTICS INC. : Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about REGULUS THERAPEUTICS INC.
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
PR
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
CI
06/21Regulus Therapeutics Gets FDA Orphan Designation for RGLS8429
DJ
06/13Regulus Reports First Individual Dosed in Early-Stage Single-Ascending Dose Trial of RG..
MT
06/13Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single-Ascending Dose (SA..
PR
06/13Regulus Therapeutics Inc. Announces First Subject Dosed in Phase 1 Single-Ascending Dos..
CI
06/02Regulus Appoints Amin Kamel, Ph.D., as Vice President, DMPK
PR
05/17Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference
PR
05/12TRANSCRIPT : Regulus Therapeutics Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12REGULUS : Q1 Earnings Snapshot
AQ
05/12Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31..
CI
05/12Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates
PR
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
MT
05/11SECTOR UPDATE : Health Care
MT
05/11Regulus Therapeutics' Shares Surge After FDA Accepts Investigational New Drug Applicati..
MT
More most relevant news
All news about REGULUS THERAPEUTICS INC.
06/28Wall Street Set to Open Higher
MT
06/28Top Premarket Decliners
MT
06/27REGULUS THERAPEUTICS INC. : Material Modification to Rights of Security Holders, Financial..
AQ
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
PR
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
CI
06/21Regulus Therapeutics Gets FDA Orphan Designation for RGLS8429
DJ
06/13REGULUS THERAPEUTICS INC. : Change in Directors or Principal Officers, Submission of Matte..
AQ
06/13Regulus Reports First Individual Dosed in Early-Stage Single-Ascending Dose Trial of RG..
MT
06/13Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single-Ascending Dose (SA..
PR
06/13Regulus Therapeutics Inc. Announces First Subject Dosed in Phase 1 Single-Ascending Dos..
CI
More news
News in other languages on REGULUS THERAPEUTICS INC.
06/21Regulus Therapeutics annonce avoir reçu la désignation de médicament orphelin de la FDA..
06/13Regulus annonce que la première personne a reçu une dose dans le cadre d'un essai de ph..
06/13Regulus Therapeutics Inc. Annonce du premier sujet traité dans le cadre de l'essai clin..
05/12Regulus Therapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 ma..
05/11MISE À JOUR SECTORIELLE : Les actions du secteur de la santé en baisse avant la clôture de..
05/11MISE À JOUR SECTORIELLE : Les actions du secteur de la santé s'accrochent encore à une pet..
05/11MISE À JOUR SECTORIELLE : Soins de santé
05/11Les actions de Regulus Therapeutics bondissent après l'acceptation par la FDA de la dem..
05/11Les actions de Regulus Therapeutics grimpent après l'acceptation par la FDA américaine ..
05/11Regulus Therapeutics Inc. annonce l'acceptation par la FDA de la demande de drogue nouv..
More news
Analyst Recommendations on REGULUS THERAPEUTICS INC.
01/21Wedbush Adjusts Regulus Therapeutics' Price Target to $0.42 From $1 Following Private E..
MT
2021REGULUS THERAPEUTICS : Cantor Fitzgerald Reinstates Regulus Therapeutics at Overweight wit..
MT
2021REGULUS THERAPEUTICS : Wedbush Halves Regulus Therapeutics' PT to $1 From $2 on RGLD4326 T..
MT
2021REGULUS THERAPEUTICS : HC Wainwright Adjusts Regulus Therapeutics' Price Target to $2 From..
MT
2021REGULUS THERAPEUTICS : Wedbush Adjusts Price Target on Regulus Therapeutics to $2 From $1,..
MT
More recommendations
Press releases
06/27REGULUS THERAPEUTICS INC. : Material Modification to Rights of Security Holders, Financial..
AQ
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
PR
06/13REGULUS THERAPEUTICS INC. : Change in Directors or Principal Officers, Submission of Matte..
AQ
06/13Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single-Ascending Dose (SA..
PR
06/02Regulus Appoints Amin Kamel, Ph.D., as Vice President, DMPK
PR
More press releases
Upcoming event on REGULUS THERAPEUTICS INC.